Drug Profile
NIK 127
Alternative Names: Lac-B-RLatest Information Update: 03 Nov 2006
Price :
$50
*
At a glance
- Originator Kowa Pharmaceutical
- Class Antidiarrhoeals; Probiotics
- Mechanism of Action Neurotransmitter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Diarrhoea
Most Recent Events
- 03 Nov 2006 Nikken Chemicals is now called Kowa Pharmaceutical
- 30 Nov 2003 Nikken Chemicals has been acquired by Kowa
- 01 Feb 2000 Launched for Diarrhoea in Japan (Unknown route)